Moreover, we also explored the distribution of IEGPI score in CR/PR and PD/SD, and the results showed that the patients with CR/PR had a higher IEGPI score (P<0.05) in melanoma patients receiving the both PD1 and CTLA4 treatment (Figure 6F). The gene discussed is CTLA4; the disease is melanoma.